Related Experiment Video
Updated: Jul 13, 2026
07:40
Gene Transfection toward Spheroid Cells on Micropatterned Culture Plates for Genetically-modified Cell Transplantation
Published on: July 31, 2015
[Dextran-spermine polycation as a vector for gene transfection in vitro]
Yuan Ping1, Qiang Ma, Jian-Hai Chen
1Department of Pharmacy, Nanfang Hospital, Guangzhou 510515, China.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|August 19, 2007
Summary
Dextran-spermine polycation (DSP) shows high efficiency as a gene vector. DSP polyplexes effectively deliver genes into cells, matching commercial standards in vitro.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Nanotechnology
Background:
- Gene therapy requires efficient and safe non-viral gene vectors.
- Developing novel polycations is crucial for improving gene delivery systems.
Purpose of the Study:
- To synthesize and characterize dextran-spermine polycation (DSP).
- To evaluate DSP's efficacy as a non-viral gene vector in vitro.
Main Methods:
- DSP synthesized via reductive amination of oxidized dextran with spermine.
- Polyplex formation by electrostatic interaction between DSP and plasmid DNA (pEGFP).
- Characterization of polyplexes (size, zeta potential, DNA protection) and transfection efficiency in SMMC-7721 and BHK-21 cells.
Main Results:
- Stable DSP/pEGFP polyplexes formed at DSP/DNA ratios of 4:1 to 20:1.
- Polyplex particle size ranged from 162.6–187.9 nm with positive zeta potentials (+8.45 to +39.6 mV).
- DSP protected DNA from degradation and exhibited buffering capacity; transfection efficiency matched Lipofectamine 2000 at an 8:1 ratio.
Conclusions:
- Dextran-spermine polycation is a promising non-viral gene vector.
- DSP demonstrates high gene transfection efficiency and DNA protection capabilities in vitro.
- DSP offers a potential alternative to existing gene delivery systems.
